InMed Pharmaceuticals Inc. Common Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for INM, updated each market day.
INM AI Sentiment
AI sees no strong directional signal for InMed Pharmaceuticals Inc. Common Shares stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About InMed Pharmaceuticals Inc. Common Shares
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
Sector
Exchange
Market Cap
$2,133,925
Cap Tier
Employees
13
Headquarters
VANCOUVER, A1
Listed Since
Nov. 10, 2020
Website
INM Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
INM Volatility
InMed Pharmaceuticals Inc. Common Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
